3α-hydroxy-24,25-epoxy-5β-cholestane | 68138-65-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: 3α-hydroxy-24,25-epoxy-5β-cholestane
• 英文别名: Cholestan-3-ol, 24,25-epoxy-, (3alpha,5beta)-；(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-4-(3,3-dimethyloxiran-2-yl)butan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
• CAS: 68138-65-8
• 化学式: C₂₇H₄₆O₂
• 分子量: 402.661
• InChiKey: YQSDWDVBVFDTRZ-AYFKJPLJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.4
• 重原子数：
  29
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  32.8
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Use of endogenous metabolites for early diagnosing sepsis
  申请人：BIOCRATES Life Sciences AG

  公开号：EP2339352A1

  公开（公告）日：2011-06-29

  The present invention relates to a use of one or a plurality of endogenous target metabolites for predicting a likelihood of an onset of a sepsis from a biological sample of a mammalian subject in vitro, wherein said endogenous target metabolites have a molecular mass less than 1500 Da and are selected from the group of oxysterols.

  本发明涉及使用一种或多种内源性目标代谢物来预测体外哺乳动物生物样本中败血症发生的可能性，其中所述内源性目标代谢物的分子质量小于 1500 Da，并且选自氧甾醇组。
• Method of diagnosing and treating asphyxia
  申请人：InfanDx AG

  公开号：US11313866B2

  公开（公告）日：2022-04-26

  A method for in vitro diagnosing asphyxia and disorders related thereto, a method of in vitro estimating duration of hypoxia in a patient subjected to asphyxia, and a method for in vitro monitoring of normoxic, hypoxic and hyperoxic conditions and/or normobaric and hyperbaric oxygen therapy, includes quantitatively detecting in a biological sample of a patient a plurality of asphyxia specific endogenous compounds which are selected from the group consisting of biogenic amines; carnitine-derived compounds; amino acids; bile acids; carboxylic acids; eicosanoids; lipids; precursors of cholesterol, cholesterol metabolites; prostanoids; and sugars.

  一种体外诊断窒息和相关疾病的方法，一种体外估计窒息患者缺氧持续时间的方法，以及一种体外监测常氧、缺氧和高氧条件和/或常压氧和高压氧治疗的方法，包括定量检测患者生物样本中多种窒息特异性内源性化合物，这些化合物选自由生物胺组成的组；氨基酸、胆汁酸、羧酸、二十酸、脂类、胆固醇前体、胆固醇代谢物、前列腺素和糖类。
• METHOD OF DIAGNOSING ASPHYXIA
  申请人：Keller, Matthias

  公开号：EP2427773A1

  公开（公告）日：2012-03-14
• Method of Diagnosing Asphyxia
  申请人：Keller Matthias

  公开号：US20120136581A1

  公开（公告）日：2012-05-31

  A method for in vitro diagnosing asphyxia and disorders related thereto, a method of in vitro estimating duration of hypoxia in a patient subjected to asphyxia, and a method for in vitro monitoring of normoxic, hypoxic and hyperoxic conditions and/or normobaric and hyperbaric oxygen therapy, includes quantitatively detecting in a biological sample of a patient a plurality of asphyxia specific endogenous compounds which are selected from the group consisting of biogenic amines; carnitine-derived compounds; amino acids; bile acids; carboxylic acids; eicosanoids; lipids; precursors of cholesterol, cholesterol metabolites; prostanoids; and sugars.
• Method of Diagnosing and Treating Asphyxia
  申请人：InfanDx AG

  公开号：US20180011111A1

  公开（公告）日：2018-01-11

  A method for in vitro diagnosing asphyxia and disorders related thereto, a method of in vitro estimating duration of hypoxia in a patient subjected to asphyxia, and a method for in vitro monitoring of normoxic, hypoxic and hyperoxic conditions and/or normobaric and hyperbaric oxygen therapy, includes quantitatively detecting in a biological sample of a patient a plurality of asphyxia specific endogenous compounds which are selected from the group consisting of biogenic amines; carnitine-derived compounds; amino acids; bile acids; carboxylic acids; eicosanoids; lipids; precursors of cholesterol, cholesterol metabolites; prostanoids; and sugars.